Takeda extends reach into vaccines with HPV deal
This article was originally published in Scrip
Executive Summary
Takeda has moved further into the vaccines sector with the licensing of exclusive global rights for the use of a patent for a human papillomavirus (HPV) vaccine held by the Japan Health Sciences Foundation (JHSF).